174 related articles for article (PubMed ID: 23551894)
1. High levels of FOXP3⁺ regulatory T cells in gastric MALT lymphoma predict responsiveness to Helicobacter pylori eradication.
Iwaya Y; Kobayashi M; Momose M; Hiraoka N; Sakai Y; Akamatsu T; Tanaka E; Ohtani H; Fukuda M; Nakayama J
Helicobacter; 2013 Oct; 18(5):356-62. PubMed ID: 23551894
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
[TBL] [Abstract][Full Text] [Related]
3. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
Begum S; Sano T; Endo H; Kawamata H; Urakami Y
J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978
[TBL] [Abstract][Full Text] [Related]
4. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.
Nakamura S; Sugiyama T; Matsumoto T; Iijima K; Ono S; Tajika M; Tari A; Kitadai Y; Matsumoto H; Nagaya T; Kamoshida T; Watanabe N; Chiba T; Origasa H; Asaka M;
Gut; 2012 Apr; 61(4):507-13. PubMed ID: 21890816
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma].
Park SH; Chi HS; Park SJ; Jang S; Park CJ; Huh JR
Korean J Lab Med; 2010 Dec; 30(6):547-53. PubMed ID: 21157137
[TBL] [Abstract][Full Text] [Related]
6. Study of regulatory T-cells in patients with gastric malt lymphoma: influence on treatment response and outcome.
García M; Bellosillo B; Sánchez-González B; García-Payarols F; Seoane A; Ferrer AM; Gimeno E; Barranco LE; Torner A; Solé F; Besses C; Serrano S; Salar A
PLoS One; 2012; 7(12):e51681. PubMed ID: 23284739
[TBL] [Abstract][Full Text] [Related]
7. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
[TBL] [Abstract][Full Text] [Related]
8. Significance of CXCR3 expression in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type for predicting responsiveness to Helicobacter pylori eradication.
Yamamoto H; Nakamura T; Matsuo K; Tajika M; Kawai H; Ohmiya N; Niwa Y; Goto H; Nakamura S
Cancer Sci; 2008 Sep; 99(9):1769-73. PubMed ID: 18616679
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to Helicobacter pylori and CagA protein are associated with the response to antibacterial therapy in patients with H. pylori-positive API2-MALT1-negative gastric MALT lymphoma.
Sumida T; Kitadai Y; Hiyama T; Shinagawa K; Tanaka M; Kodama M; Masuda H; Ito M; Tanaka S; Yoshihara M; Chayama K
Cancer Sci; 2009 Jun; 100(6):1075-81. PubMed ID: 19385974
[TBL] [Abstract][Full Text] [Related]
10. Rapid development of diffuse large B-Cell lymphoma after successful eradication of Helicobacter pylori for gastric MALT lymphoma.
Iwano M; Watanabe N; Matsushima Y; Seno H; Oki K; Sakurai T; Inagaki H; Okazaki K; Chiba T
Am J Gastroenterol; 2006 Dec; 101(12):2878-83. PubMed ID: 17026570
[TBL] [Abstract][Full Text] [Related]
11. The variation of expression of CD4+ CD25+ Foxp3+ regulatory T cells in patients with Helicobacter pylori infection and eradication.
Chen T; Jin R; Huang Z; Hong W; Chen Z; Wang J
Hepatogastroenterology; 2010; 57(99-100):430-5. PubMed ID: 20698203
[TBL] [Abstract][Full Text] [Related]
12. FOXP3-expressing CD4(+) T-cell numbers increase in areas of duodenal gastric metaplasia and are associated to CD4(+) T-cell aggregates in the duodenum of Helicobacter pylori-infected duodenal ulcer patients.
Kindlund B; Sjöling A; Hansson M; Edebo A; Hansson LE; Sjövall H; Svennerholm AM; Lundin BS
Helicobacter; 2009 Jun; 14(3):192-201. PubMed ID: 19702849
[TBL] [Abstract][Full Text] [Related]
13. A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication.
Hong SS; Jung HY; Choi KD; Song HJ; Lee GH; Oh TH; Jo JY; Kim KJ; Byeon JS; Myung SJ; Yang SK; Hong WS; Kim JH; Min YI
Helicobacter; 2006 Dec; 11(6):569-73. PubMed ID: 17083379
[TBL] [Abstract][Full Text] [Related]
14. Immunological and molecular analysis of B lymphocytes in low-grade MALT lymphoma of the stomach. Are there any useful markers for predicting outcome after Helicobacter pylori eradication?
Matsushima Y; Kinoshita Y; Fukui H; Maekawa T; Yazumi S; Okada A; Nakase H; Kawanami C; Iwano M; Hashimoto K; Takeda Z; Okazaki K; Chiba T
J Gastroenterol; 2002; 37(6):428-33. PubMed ID: 12108676
[TBL] [Abstract][Full Text] [Related]
15. Patients with Helicobacter pylori negative gastric marginal zone b-cell lymphoma (MZBCL) of MALT have a good prognosis.
Al-Taie O; Al-Taie E; Fischbach W
Z Gastroenterol; 2014 Dec; 52(12):1389-93. PubMed ID: 25474277
[TBL] [Abstract][Full Text] [Related]
16. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
[TBL] [Abstract][Full Text] [Related]
17. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
[TBL] [Abstract][Full Text] [Related]
18. The variation of expression of CD4+ CD25+ Foxp3+ regulatory T cells in patients with Helicobacter pylori infection and eradication.
Chen T; Jin R; Huang Z; Hong W; Chen Z; Wang J
Hepatogastroenterology; 2014; 61(130):507-11. PubMed ID: 24901172
[TBL] [Abstract][Full Text] [Related]
19. Consecutive regression of concurrent laryngeal and gastric MALT lymphoma after anti-Helicobacter pylori therapy.
Caletti G; Togliani T; Fusaroli P; Sabattini E; Khodadadian E; Gamberi B; Gobbi M; Pileri S
Gastroenterology; 2003 Feb; 124(2):537-43. PubMed ID: 12557157
[TBL] [Abstract][Full Text] [Related]
20. Management and long-term follow-up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: an Italian, multicentre study.
Andriani A; Miedico A; Tedeschi L; Patti C; Di Raimondo F; Leone M; Schinocca L; Romanelli A; Bonanno G; Linea C; Giustini M; Hassan C; Cottone M; Zullo A
Dig Liver Dis; 2009 Jul; 41(7):467-73. PubMed ID: 18945654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]